Cargando…
Cannabigerol modulates α(2)-adrenoceptor and 5-HT(1A) receptor-mediated electrophysiological effects on dorsal raphe nucleus and locus coeruleus neurons and anxiety behavior in rat
The pharmacological profile of cannabigerol (CBG), which acid form constitutes the main precursor of the most abundant cannabinoids, has been scarcely studied. It has been reported to target α(2-)adrenoceptor and 5-HT(1A) receptor. The locus coeruleus (LC) and the dorsal raphe nucleus (DRN) are the...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249961/ https://www.ncbi.nlm.nih.gov/pubmed/37305529 http://dx.doi.org/10.3389/fphar.2023.1183019 |
_version_ | 1785055656887189504 |
---|---|
author | Mendiguren, Aitziber Aostri, Erik Rodilla, Irati Pujana, Iker Noskova, Ekaterina Pineda, Joseba |
author_facet | Mendiguren, Aitziber Aostri, Erik Rodilla, Irati Pujana, Iker Noskova, Ekaterina Pineda, Joseba |
author_sort | Mendiguren, Aitziber |
collection | PubMed |
description | The pharmacological profile of cannabigerol (CBG), which acid form constitutes the main precursor of the most abundant cannabinoids, has been scarcely studied. It has been reported to target α(2-)adrenoceptor and 5-HT(1A) receptor. The locus coeruleus (LC) and the dorsal raphe nucleus (DRN) are the main serotonergic (5-HT) and noradrenergic (NA) areas in the rat brain, respectively. We aimed to study the effect of CBG on the firing rate of LC NA cells and DRN 5-HT cells and on α(2)-adrenergic and 5-HT(1A) autoreceptors by electrophysiological techniques in male Sprague-Dawley rat brain slices. The effect of CBG on the novelty-suppressed feeding test (NSFT) and the elevated plus maze test (EPMT) and the involvement of the 5-HT(1A) receptor was also studied. CBG (30 μM, 10 min) slightly changed the firing rate of NA cells but failed to alter the inhibitory effect of NA (1–100 µM). However, in the presence of CBG the inhibitory effect of the selective α(2)-adrenoceptor agonist UK14304 (10 nM) was decreased. Perfusion with CBG (30 μM, 10 min) did not change the firing rate of DRN 5-HT cells or the inhibitory effect of 5-HT (100 μM, 1 min) but it reduced the inhibitory effect of ipsapirone (100 nM). CBG failed to reverse ipsapirone-induced inhibition whereas perfusion with the 5-HT(1A) receptor antagonist WAY100635 (30 nM) completely restored the firing rate of DRN 5-HT cells. In the EPMT, CBG (10 mg/kg, i.p.) significantly increased the percentage of time the rats spent on the open arms and the number of head-dipping but it reduced the anxiety index. In the NSFT, CBG decreased the time latency to eat in the novel environment but it did not alter home-cage consumption. The effect of CBG on the reduction of latency to feed was prevented by pretreatment with WAY100635 (1 mg/kg, i.p.). In conclusion, CBG hinders the inhibitory effect produced by selective α(2)-adrenoceptor and 5-HT(1A) receptor agonists on the firing rate of NA-LC and 5-HT-DRN neurons by a yet unknown indirect mechanism in rat brain slices and produces anxiolytic-like effects through 5-HT(1A) receptor. |
format | Online Article Text |
id | pubmed-10249961 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102499612023-06-09 Cannabigerol modulates α(2)-adrenoceptor and 5-HT(1A) receptor-mediated electrophysiological effects on dorsal raphe nucleus and locus coeruleus neurons and anxiety behavior in rat Mendiguren, Aitziber Aostri, Erik Rodilla, Irati Pujana, Iker Noskova, Ekaterina Pineda, Joseba Front Pharmacol Pharmacology The pharmacological profile of cannabigerol (CBG), which acid form constitutes the main precursor of the most abundant cannabinoids, has been scarcely studied. It has been reported to target α(2-)adrenoceptor and 5-HT(1A) receptor. The locus coeruleus (LC) and the dorsal raphe nucleus (DRN) are the main serotonergic (5-HT) and noradrenergic (NA) areas in the rat brain, respectively. We aimed to study the effect of CBG on the firing rate of LC NA cells and DRN 5-HT cells and on α(2)-adrenergic and 5-HT(1A) autoreceptors by electrophysiological techniques in male Sprague-Dawley rat brain slices. The effect of CBG on the novelty-suppressed feeding test (NSFT) and the elevated plus maze test (EPMT) and the involvement of the 5-HT(1A) receptor was also studied. CBG (30 μM, 10 min) slightly changed the firing rate of NA cells but failed to alter the inhibitory effect of NA (1–100 µM). However, in the presence of CBG the inhibitory effect of the selective α(2)-adrenoceptor agonist UK14304 (10 nM) was decreased. Perfusion with CBG (30 μM, 10 min) did not change the firing rate of DRN 5-HT cells or the inhibitory effect of 5-HT (100 μM, 1 min) but it reduced the inhibitory effect of ipsapirone (100 nM). CBG failed to reverse ipsapirone-induced inhibition whereas perfusion with the 5-HT(1A) receptor antagonist WAY100635 (30 nM) completely restored the firing rate of DRN 5-HT cells. In the EPMT, CBG (10 mg/kg, i.p.) significantly increased the percentage of time the rats spent on the open arms and the number of head-dipping but it reduced the anxiety index. In the NSFT, CBG decreased the time latency to eat in the novel environment but it did not alter home-cage consumption. The effect of CBG on the reduction of latency to feed was prevented by pretreatment with WAY100635 (1 mg/kg, i.p.). In conclusion, CBG hinders the inhibitory effect produced by selective α(2)-adrenoceptor and 5-HT(1A) receptor agonists on the firing rate of NA-LC and 5-HT-DRN neurons by a yet unknown indirect mechanism in rat brain slices and produces anxiolytic-like effects through 5-HT(1A) receptor. Frontiers Media S.A. 2023-05-25 /pmc/articles/PMC10249961/ /pubmed/37305529 http://dx.doi.org/10.3389/fphar.2023.1183019 Text en Copyright © 2023 Mendiguren, Aostri, Rodilla, Pujana, Noskova and Pineda. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Mendiguren, Aitziber Aostri, Erik Rodilla, Irati Pujana, Iker Noskova, Ekaterina Pineda, Joseba Cannabigerol modulates α(2)-adrenoceptor and 5-HT(1A) receptor-mediated electrophysiological effects on dorsal raphe nucleus and locus coeruleus neurons and anxiety behavior in rat |
title | Cannabigerol modulates α(2)-adrenoceptor and 5-HT(1A) receptor-mediated electrophysiological effects on dorsal raphe nucleus and locus coeruleus neurons and anxiety behavior in rat |
title_full | Cannabigerol modulates α(2)-adrenoceptor and 5-HT(1A) receptor-mediated electrophysiological effects on dorsal raphe nucleus and locus coeruleus neurons and anxiety behavior in rat |
title_fullStr | Cannabigerol modulates α(2)-adrenoceptor and 5-HT(1A) receptor-mediated electrophysiological effects on dorsal raphe nucleus and locus coeruleus neurons and anxiety behavior in rat |
title_full_unstemmed | Cannabigerol modulates α(2)-adrenoceptor and 5-HT(1A) receptor-mediated electrophysiological effects on dorsal raphe nucleus and locus coeruleus neurons and anxiety behavior in rat |
title_short | Cannabigerol modulates α(2)-adrenoceptor and 5-HT(1A) receptor-mediated electrophysiological effects on dorsal raphe nucleus and locus coeruleus neurons and anxiety behavior in rat |
title_sort | cannabigerol modulates α(2)-adrenoceptor and 5-ht(1a) receptor-mediated electrophysiological effects on dorsal raphe nucleus and locus coeruleus neurons and anxiety behavior in rat |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249961/ https://www.ncbi.nlm.nih.gov/pubmed/37305529 http://dx.doi.org/10.3389/fphar.2023.1183019 |
work_keys_str_mv | AT mendigurenaitziber cannabigerolmodulatesa2adrenoceptorand5ht1areceptormediatedelectrophysiologicaleffectsondorsalraphenucleusandlocuscoeruleusneuronsandanxietybehaviorinrat AT aostrierik cannabigerolmodulatesa2adrenoceptorand5ht1areceptormediatedelectrophysiologicaleffectsondorsalraphenucleusandlocuscoeruleusneuronsandanxietybehaviorinrat AT rodillairati cannabigerolmodulatesa2adrenoceptorand5ht1areceptormediatedelectrophysiologicaleffectsondorsalraphenucleusandlocuscoeruleusneuronsandanxietybehaviorinrat AT pujanaiker cannabigerolmodulatesa2adrenoceptorand5ht1areceptormediatedelectrophysiologicaleffectsondorsalraphenucleusandlocuscoeruleusneuronsandanxietybehaviorinrat AT noskovaekaterina cannabigerolmodulatesa2adrenoceptorand5ht1areceptormediatedelectrophysiologicaleffectsondorsalraphenucleusandlocuscoeruleusneuronsandanxietybehaviorinrat AT pinedajoseba cannabigerolmodulatesa2adrenoceptorand5ht1areceptormediatedelectrophysiologicaleffectsondorsalraphenucleusandlocuscoeruleusneuronsandanxietybehaviorinrat |